Join our monthly newsletter to help you stay informed on current research as well as support and upcoming events.
Past Lupus Link Newsletters
2024 Newsletters
2023 Newsletters
2022-2020 Newsletters
This Lupus Ontario petition is advocating to have the Ontario government approve all biologics approved by the Federal Health Agency (CADTH) added to the Ontario Drug Formulary under the Limited Use code rather that the Exceptional Access Program. The Limited Use code eliminates the administrative burden for rheumatologists and provides faster access for lupus patients. Please print and gather signatures and send it to our address: 285 Taunton Road East, Suite 4438, Oshawa, ON L1G 3V2 Canada